PURIST
Live / Registered — Registered (as of 11 Mar 2025)
What this means for you
Registered since 11 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97979703
- Registration number
- 7725072
- Mark type
- Stylized text
- Filed
- 22 Dec 2022
- Published for opposition
- 09 Apr 2024
- Registered
- 11 Mar 2025
- Attorney of record
- Devon E. White
Goods and services
- Class 042 — Scientific and technological services: Providing medical and scientific research in the field of oncology, tumor biology, and diagnosis and treatment of cancers; Pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; Providing research and development services in the field of oncology; Research and development in the field of RNA expression, namely, cancer biology; Research and development services for others, namely, research and development of assays for oncological testing and diagnostic purposes; Scientific research in the field of RNA expression analysis and reporting; Providing laboratory research services in the field of pancreatic cancer; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Pharmaceutical and medical research in the field of survival outcomes and standard of care research; Medical research featuring the identification and validation of cancer related biomarkers and RNA expression for use in improved patient outcomes; Providing a website and information in the field of medical research and scientific research in the fields of tumor biology, oncology, and diagnosis and treatment of cancers
- Class 044 — Medical, beauty and agricultural services: Medical testing services for diagnosis, prognosis, treatment, and management of cancer; Medical testing for diagnostic and treatment option purposes; Providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the diagnosis, prognosis, treatment or management of cancer; Provision of health care services, namely, providing oncological testing reports to physicians
Owner
- GENECENTRIC THERAPEUTICS, INC., Durham, NC, US
- GENECENTRIC THERAPEUTICS, INC., Durham, NC, US
- GENECENTRIC THERAPEUTICS, INC., Durham, NC, US
Prosecution history
- 11 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 20 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Oct 2024 — USE AMENDMENT FILED
- 13 Feb 2025 — SOU EXTENSION 1 GRANTED
- 01 Oct 2024 — SOU EXTENSION 1 FILED
- 13 Feb 2025 — DIVISIONAL PROCESSING COMPLETE
- 01 Oct 2024 — DIVISIONAL REQUEST RECEIVED
- 10 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Oct 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 01 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 01 Oct 2024 — SOU TEAS EXTENSION RECEIVED